In prostate cancer, the feedback loops between these pathways is disrupted, leading to increased amounts of LDLR at the cell surface and thereby elevating uptake of LDL-derived cholesterol, altogether raising cellular cholesterol levels [16]. The gene discussed is LDLR; the disease is prostate carcinoma.